Isabelle Côté Selected Research

Intravaginal Administration

11/2018	Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
3/2016	Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
1/2016	Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator.
5/2015	Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.
11/2013	Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
9/2008	Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Côté Research Topics

Disease

14	Atrophy 11/2018 - 09/2008
7	Pain (Aches) 01/2019 - 09/2009
5	Dyspareunia 11/2018 - 07/2014
3	Neoplasms (Cancer) 08/2016 - 10/2002
2	Spastic ataxia Charlevoix-Saguenay type 10/2021 - 10/2018
2	Body Weight (Weight, Body) 11/2018 - 01/2018
2	Infections 02/2017 - 06/2003
2	Breast Neoplasms (Breast Cancer) 04/2014 - 09/2008
1	Myotonic Dystrophy (Dystrophia Myotonica) 04/2021
1	Nausea 01/2019
1	Apnea 01/2019
1	Vomiting 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Polycythemia Vera 08/2016
1	Pruritus (Itching) 08/2016
1	Primary Myelofibrosis (Myelosclerosis) 01/2015
1	Intestinal Perforation 04/2014
1	Febrile Neutropenia 04/2014
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2013
1	Neuralgia (Stump Neuralgia) 09/2013
1	Death (Near-Death Experience) 02/2013
1	Brain Death (Brain Dead) 02/2013
1	Delayed Graft Function 02/2013
1	Leigh Disease (Leigh's Disease) 01/2011
1	Cytochrome-c Oxidase Deficiency 01/2011
1	Uterine Neoplasms (Uterine Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

13	Dehydroepiandrosterone (DHEA)IBA 11/2018 - 09/2008
7	Estrogens (Estrogen)FDA Link 07/2014 - 10/2002
3	salicylhydroxamic acid (SHAM)IBA 11/2018 - 09/2013
3	SteroidsIBA 07/2014 - 09/2009
2	LeptinIBA 11/2018 - 01/2018
2	ruxolitinibIBA 08/2016 - 01/2015
2	Oral ContraceptivesIBA 02/2003 - 10/2002
1	Dexmedetomidine FDA Link 01/2019
1	Remifentanil (Ultiva)FDA Link 01/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2018
1	Antiviral Agents (Antivirals)IBA 02/2017
1	Syntex adjuvant formulationIBA 08/2016
1	Suppositories (Vaginal Suppositories)IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 04/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2014
1	Testosterone (Sustanon)FDA Link 11/2013
1	Analgesics (Analgesic Drugs)IBA 09/2013
1	dicarboxydine (DCD)IBA 02/2013
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2011
1	Leucine (L-Leucine)FDA Link 01/2011
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	AndrogensIBA 09/2009
1	AmproliumIBA 06/2003
1	ClopidolIBA 06/2003

Therapy/Procedure

6	Intravaginal Administration 11/2018 - 09/2008
2	Activities of Daily Living (ADL) 04/2021 - 10/2018
1	Walkers 10/2021
1	Anesthesia 01/2019
1	Denervation 01/2018
1	Traditional Medicine (Folk Remedies) 02/2017
1	Therapeutics 08/2016
1	Transcranial Magnetic Stimulation 09/2013